Forte Biosciences, Inc. (FBRX) Stock Grade

About Forte Biosciences, Inc.'s fundamentals

Forte Biosciences is a biotechnology company with a market capitalization of $4.0 billion that is currently unprofitable, having reported a net loss in its latest annual statement with a net margin of 0.0%. The company generated no year-over-year revenue growth, indicating flat sales performance in its most recent reporting period. As a pre- or early-revenue biotech firm, traditional valuation metrics like P/E ratio and return on equity are not applicable, and the company does not pay a dividend. Investors should note that profitability and growth metrics typical of established pharmaceutical companies are not yet present in Forte's financial picture.